Salivary matrix metalloproteinases activity in periodontal disease
Journal Title: Revista de Medicină Militară - Year 2019, Vol 0, Issue 1
Abstract
Introduction: Matrix metalloproteinases (MMPs) are key enzymes involved in degradation of extracellular colagen matrix during periodontal disease progression. The aim of our work was to study the levels of MMP-1, MMP-2, MMP-7, MMP-9 and MMP-10 in saliva of patients with chronic periodontitis. Materials and methods: The study included 22 patients with chronic periodontal disease and 15 controls. We collect unstimulated whole saliva from all volunteers included in the study. Salivary levels of mentioned MMPs were analyzed using magnetic bead-based multiplex assays and Luminex technology. Results: MMP-1, MMP-7, MMP-9 and MMP-10 present statistically increased salivary levels at patients with periodontal disease versus the control group (p<0.05). Salivary level of MMP-2 at patients with chronic periodontitis was increased but statistically insignificant compared with healthy subjects (p=0.1). Conclusions. The increased level of these enzymes in patients diagnosed with periodontal disease reflects their implication in periodontal tissue degradation. Saliva is an excellent fluid useful in monitoring the severity of this oral disease that affects about half of the adult population around the world
Authors and Affiliations
Daniela Miricescu, Constantin Stefani, Iulia Stanescu, Alexandra Totan, Radu Radulescu, Andreea Didilescu, Lidia Ciobanu, Maria Greabu
Keywords
Related Articles
- EP ID EP481533
- DOI -
- Views 57
- Downloads 0
Emerging concepts regarding the molecular profile of breast carcinoma: one-year experience in a University Center
Breast carcinoma represents the leading cause of oncologic mortality for women. Due to therapeutic and diagnostic advances, the mortality and morbidity in the last decade declined, but breast cancer still has a great imp...
New synthesized oximes active in nerve agents’ hazards
Object: The aim of the study is to select the most active new imidazolium-quinuclidinum-oxime, from some similar chemical compounds synthesized in our chemistry department, with sufficient efficacy to decrease the acute...
The not so good and the not so bad
-
Therapeutic management of schizophrenia and substance use disorders dual diagnosis – clinical vignettes
Patients with schizophrenia are frequently diagnosed with addictive comorbidities, and data in the literature support a 10 to 70% prevalence of this dual diagnosis. Nonetheless, substance use disorders can be missed duri...
Academician General Victor Voicu at the anniversary
-